---
title: "Align Technology beats fourth-quarter results estimates on dental products demand"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274882640.md"
description: "Align Technology reported better-than-expected fourth-quarter results, driven by strong demand for dental aligners, with shares rising over 10% in after-hours trading. The company forecasts first-quarter revenue between $1.01 billion and $1.03 billion, aligning with analyst estimates. Despite recent sluggish demand for dental products, analysts anticipate a more stable market by 2026. Align's adjusted profit was $3.29 per share, surpassing estimates of $2.97, with revenues of $1.05 billion exceeding expectations of $1.03 billion."
datetime: "2026-02-04T23:14:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274882640.md)
  - [en](https://longbridge.com/en/news/274882640.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274882640.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274882640.md) | [繁體中文](https://longbridge.com/zh-HK/news/274882640.md)


# Align Technology beats fourth-quarter results estimates on dental products demand

By Unnamalai L

Feb 4 (Reuters) - Align Technology (ALGN.O) reported quarterly results above Wall Street expectations and forecast first-quarter revenue in line with estimates, driven by strong demand for its dental aligners.

Shares of the company were up more than 10% in after-hours trading.

Demand for dental products has been sluggish in the past few quarters due to uneven dental visits. Analysts expect 2026 to see more stable demand, although they remain cautious about a full recovery in the broader market.

Align, which makes teeth retainers, dental scanners and software for dental laboratories and practitioners, expects its first-quarter global revenue to be between $1.01 billion and $1.03 billion, compared with analysts’ estimates of $1.02 billion, according to data compiled by LSEG.

“Align finished off 2025 on a high note,” said Evercore ISI Elizabeth Anderson, noting that the initial 2026 revenue outlook appears both encouraging and prudent.

First-quarter revenue outlook is broadly in line with analysts’ expectations, though stronger pricing and mid-single-digit case growth could lift results, Anderson added.

The company expects volume growth for its flagship product, Clear Aligner, to be up mid-single digits on a year-over-year basis in 2026, compared to growth of 4.7% in 2025.

It expects annual revenue growth to be up 3% to 4% year-over-year.

On an adjusted basis, the company earned a profit of $3.29 per share for the quarter ended December 31, beating analysts’ estimates of $2.97 per share. Revenues of $1.05 billion were above estimates of $1.03 billion.

### Related Stocks

- [Align Technology, Inc. (ALGN.US)](https://longbridge.com/en/quote/ALGN.US.md)

## Related News & Research

- [10 Analysts Have This To Say About Align Technology](https://longbridge.com/en/news/277080844.md)
- [Edwards Lifesciences Corp Officer Sells Shares](https://longbridge.com/en/news/277530403.md)
- [Align Technology Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/267182176.md)
- [Savant Capital LLC Decreases Stock Holdings in Align Technology, Inc. $ALGN](https://longbridge.com/en/news/275591889.md)
- [Align Technology Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/268671666.md)